PAPER: RECENT DEVELOPMENTS IN THE MANAGEMENT OF ATRIAL FIBRILLATION

1 Go AS EM Hylek Phillips KA Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285:2370-5.

2 Luderitz B Jung W. Quality of life in atrial fibrillation. J Interv Card Electrophysiol 2000; 4(Suppl 1):201-9.

3 Wolf PA JB Mitchell Baker CS Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998; 158:229-34.

4 Fuster V LE Ryden Asinger RW ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104:2118-50.

5Royal College of Physicians of Edinburgh. Consensus Conference on Atrial Fibrillation in Hospital and General Practice. Consensus Statement. Proc R Coll Physicians Edinb 1998; 28(4):552-4.

6 Kannel WB RD Abbott Savage DD Epidemiologic features of chronic atrial fibrillation:the Framingham study. N Engl J Med 1982; 306:1018-22.

7 Krahn AD J Manfreda Tate RB The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98:476-84.

8 Cain ME. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1822-3.

9 Van Gelder IC VE Hagens Bosker HA A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347:1834-40.

10Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154:1449-57.

11 Segal JB RL McNamara Miller MR Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med 2000; 15:56-67.

12 Sudlow M R Thomson Thwaites B Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352:1167-71.

13 Oden A Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002; 325:1073-5.

14 Petersen P M Grind Adler J. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study. J Am Coll Cardiol 2003; 41:1445-51.

15 Olsson SB. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet 2003; 362:1691-8.

16 Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 2003; 29:469-89.

17 Ermis C AX Zhu Sinha S Efficacy of biphasic waveform cardioversion for atrial fibrillation and atrial flutter compared with conventional monophasic waveforms. Am J Cardiol 2002; 90:891-2.

18 Mittal S S Ayati Stein KM Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000; 101:1282-7.

19 Schmitt C Ndrepepa G. Use of atrial defibrillators to convert atrial fibrillation at home: psychosocial aspects. J Cardiovasc Electrophysiol 2003; 14:817-18.

20 Roy D M Talajic Dorian P Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000; 342:913-20.

21Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003; 42:20-9.

22 Falk RH A Pollak Singh SN Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol 1997; 29:385-90.

23 Singh S RG Zoble Yellen L Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 2000; 102:2385-90.

24 Andersen HR JC Nielsen Thomsen PE Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350:1210-16.

25 Gillis AM Kerr CR. Whither physiologic pacing? Implications of CTOPP. Pacing Clin Electrophysiol 2000; 23:1193-6.

26 Lamas GA KL Lee Sweeney MO Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854-62.

27 Carlson MD J Ip Messenger J A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003; 42:627-33.

28 Saksena S A Prakash RB Krol , Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation. Am J Cardiol 1999; 84:880-9.

29 Saksena S A Shankar Prakash A Catheter mapping of spontaneous and induced atrial fibrillation in man. J Interv Card Electrophysiol 2000; 4(Suppl 1):2l-8.

30 Friedman PA B Dijkman Warman EN Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001; 104:1023-8.

31 Israel CW JR Ehrlich Gronefeld G Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device. J Am Coll Cardiol 2001; 38:355-63.

32 Cox JL RB Schuessler D'Agostino HJ Jr The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991; 101:569-83.

33 Gaita F R Gallotti Calo L Limited posterior left atrial cryoablation in patients with chronic atrial fibrillation undergoing valvular heart sugery. J Am Coll Cardiol 2000; 36:159-66.

34 Scheinman MM Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 2000; 23:1020-8.

35 Haissaguerre M P Jais Shah DC Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659-66.

36 Pappone C S Rosanio ,Augello G Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation fo atrial fibrillation. J Am Coll Cardiol 2003; 42:185-97.